61 (look-see) "Tickers" Double 00 to $5. Charts

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
61 (look-see) "Tickers"

Double 00 to $5.

Charts and logos linked to updates.

PPS showing is from date called here.


AGCZ. $0.0016 breakout needs follow thru

EWSI. $0.034  breakout

PRHL. $0.25 a top resistance.

FONU. $0.27  low volume climber

ESEA $1.15 at resistance

PTAH. $0.0014 trucker reversal

MCZ. $0.58 up channel at support

CZICF $0,65 at breakout.

NTRR. $0.90 reversal

SBOTF  $1.32 biotech climber

DRYS. $2.04 shipper on watch for breakou

P STI $3.27 breakout

BRAV. $0.0104 at resistance

GDSI. $1.07 upturn

GLOW. $1.13 reversal

DVR.  $2.28 breakout

BNLB $0.25 new climber

FBTN. $0.89 low volume uptrend

WMIH. $1.04 low volume uptrend

SMT. $2.32 new volume gap

MWIP.  $0.0417 breakout/rebound

CSY. $0.05  climber with a candle

AVL. $0.92 flag and candle.

HNSN. $1.87 new volume breakout

PACB. $3.33 breakout candle

ARDM. $0.198 reversal.

BSDM. $1.70 breakout

FLST. $0.12 /  2 upticks off the bottom

CCNI. $0.31 new uptrend

SFES. $0.69 at resistance

SRCO. $0.72 up-volume climber

AEMD. $0.16 climbing candle

HKFI. $1.11 up channel at resistance

OTIV. $1.71 up channel at resistance

III. $2.75 month long climb

DDXS. $1.22 new volume climber.

VASO.  $0.18 / 8-month-consolidation &n

APHB. $0.65 upturn pull back.

TOMZ. $0,71 low volume flag breakout

NTS. $1.76 climber

CRWN.  $2.78 staged low volume.

ARC. $4.96 / 8 months off double bottom.

URRE. $3.35 breakout.

UEC. $2.52 breakout

BLFR. $0.63 new volume churn.

DVD. $2.26 steady climber.

CIBH. $0.59 low volume higher low s.

CTHR. $4.82 breakout.

HOTR. $3.94 breakout.

WSTL. $2.63 climber.

ZHNE. $2.14 breakout.

SNV. $3.24 breakout.

BLDW. $0.045 breakout.

MINE. $0.0028 near breakout.

DSNY. $1.33 climber.

AFFM. $1.00 low volume climber.

ECSL. $0.42 (1 year) ascending triangle.

INTT. $3.66 up channel at support.

EAHC. $0.392 recent volume climber.

AMNF. $1.36 solid uptrend.

ZERO. $1.09 correction at support.

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Hims & Hers Health Faces Revenue Challenges and Legal Issues

Updated Category News Views 246

Hims & Hers Revenue Challenges Amid Stock Decline In recent trading sessions, Hims & Hers Health reported notable stock fluctuations as the company unveiled a decline in revenue per customer linked to its customization of GLP-1 medications for weight loss. This announcement caused an almost 11% drop in the stock price. Impacts of Collaboration Termination This steep...

Continue Reading
Entrée Resources Reports Solid Results for Q3 2025

Updated Category News Views 166

Entrée Resources Ltd. Overview Entrée Resources Ltd. (TSX: ETG; OTCQB: ERLFF), a reputable Canadian mining company focused on the Oyu Tolgoi project, has announced its interim financial results for the third quarter of 2025. This announcement sheds light on its ongoing operations and future plans, emphasizing the company's significant role in one of the world's largest...

Continue Reading
Bucket List Wine Dinners Beckon to Los Angeles

Updated Category News Views 10

Sipping on the Extraordinary: LA Wine Soiree When was the last time you had a glass of wine that truly feels like you've unlocked a treasure chest? That's what LearnAboutWine.com is going for with their bucket list wine dinners in Los Angeles. Imagine tasting some of the world's most coveted bottles, all served with a level of polish that screams high-end dining. Led by...

Continue Reading
BioLife Solutions Enhances Growth Potential with $73 Million Sale

Updated Category News Views 68

BioLife Solutions Announces $73 Million Sale of SciSafe In a significant move aimed at reinforcing its strategic direction, BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the development and supply of cell processing tools and services for the cell and gene therapy market, has announced the sale of its biostorage subsidiary, SciSafe Holdings, Inc. The...

Continue Reading
Advancements in Universal Vaccine Development by Dx&Vx

Updated Category News Views 154

Innovative Pathway Towards a Universal COVID-19 Vaccine In the wake of a global resurgence of COVID-19, Dx&Vx (DXVX) is stepping up its efforts to develop a universal vaccine aimed at providing protection against all variants of the virus. With the recent acquisition of cutting-edge technology, this next-generation vaccine is set to attract significant global interest....

Continue Reading